Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin plus PTNS for Urgency Urinary Incontinence
NCT02176642Phase 4Terminated
- Sponsor
- Duke University
- Start
- Aug 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxybutynin in urge incontinence, sponsored by Duke University. Started Aug 2014; status: terminated.
02
Drugs
oxybutynin
03
Conditions
urge incontinence
Beyond the preview
Go deeper on NCT02176642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176642.